Spots Global Cancer Trial Database for Evaluation of ClearLLab Leukemia and Lymphoma Panels
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Evaluation of ClearLLab Leukemia and Lymphoma Panels
Official Title: Evaluation of ClearLLab Leukemia and Lymphoma Panels
Study ID: NCT03413644
Conditions
Interventions
Study Description
Brief Summary: Multi-center study of specimens from subjects presenting to the flow cytometry laboratory as part of their standard of care for hematological diseases work-up.
Detailed Description: Multi-center study of specimens from subjects presenting for flow cytometry immunophenotyping as part of their standard of care for hematological diseases work-up. Residual specimens will be tested using the ClearLLab Panels to determine the presence or absence of an abnormal phenotype and compare results to clinical impression (hematological malignancy or non-malignancy).
Keywords
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
NeoGenomics Laboratories, Inc., Fort Myers, Florida, United States
Calgary Laboratory Services, Calgary, Alberta, Canada
London Health Sciences Center, London, Ontario, Canada
Munich Leukemia Laboratory, Munich, , Germany
Contact Details
Name: Adrian Padurean, MD
Affiliation: NeoGenomics Laboratories, Inc.
Role: PRINCIPAL_INVESTIGATOR
Name: Mike Keeney
Affiliation: London Health Sciences Center
Role: PRINCIPAL_INVESTIGATOR
Name: Joanne Luider
Affiliation: Calgary Laboratory Services
Role: PRINCIPAL_INVESTIGATOR
Name: Wolfgang Kern
Affiliation: Munich Leukemia Laboratory
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
